China Focus: New policies set to ease burden for China's cancer patients

    Source: Xinhua| 2018-04-14 17:08:53|Editor: Yurou
    Video PlayerClose

    BEIJING, April 14 (Xinhua) -- A series of new policies on anticancer drugs in China will give hope to the country's cancer patients.

    According to the statement released after an executive meeting of the State Council on Thursday, from May 1, import tariffs on all common drugs including cancer drugs, cancer alkaloid-based drugs, and imported traditional Chinese medicine will be exempted.

    Also, value added tax in the production and import of drugs will drop by a large margin, which experts believe will be more effective in easing the economic burden of patients.

    With various measures taken into consideration, it is estimated that the policies will lower the drug prices by at least 20 percent, said Shi Luwen, director of the international research center on medicine management at Peking University.

    The measures will significantly enhance the availability and inclusiveness of the drugs, reduce the burden of patients' families, and will help prevent poverty caused by illness, he said.

    Statistics indicate that many cancer patients in China have been struggling to acquire cheap, quality medicine.

    According to the national cancer institute, the market for antineoplastic drugs in China exceeds 120 billion yuan (about 19.1 billion U.S. dollars). However, they are usually too expensive for working class families.

    "We are speeding up in making high-quality generic drugs available in the market, but most of the targeted anticancer drugs were still imported," said Liu Lihong, a doctor at the Beijing Chaoyang Hospital.

    Chen Wenming, another doctor at the hospital, said that despite social insurance, patients in Beijing still have to pay 20 percent of the total price of the drugs. The percentage is even higher in less developed areas.

    For this, the State Council put forward a solution at the meeting, asking for the timely inclusion of imported new drugs in the range of medical insurance, especially urgent cancer drugs.

    In addition, the import procedures of new medicine will be streamlined, as importing enterprises will take charge of the examination of the drugs, instead of compulsory examination by authorities.

    "It will make it easier for patients to access the drugs in terms of timing," said Shi Luwen. "It also adds to the enterprises' responsibilities to ensure the quality and safety of the drugs, while saving their time."

    As for the long term, experts are expecting higher capabilities of medical institutions on the grassroots level, and the balance of the share of drugs in different areas, so that urgent medicine including anticancer drugs can more efficiently and accurately benefit the people.

    "More measures will soon be implemented to make sure those in urgent need of medicine can get sufficient, quality and cheaper drugs in time," the National Health Commission said.

    TOP STORIES
    EDITOR’S CHOICE
    MOST VIEWED
    EXPLORE XINHUANET
    010020070750000000000000011100001371109981
    主站蜘蛛池模板: 奇米四色在线视频| 最新中文字幕一区| 国产三区视频在线观看| 2020天堂中文字幕一区在线观| 成人性一级视频在线观看| 亚洲三级在线免费观看| 男生和女生一起差差差很痛视频 | 天天干天天爽天天射| 久久人人爽人人爽人人片AV东京热 | 在线观看不卡视频| 国产福利一区二区精品秒拍| 一级黄色a毛片| 日韩福利电影网| 又粗又硬又大又爽免费视频播放 | 日本精品视频一区二区| 公的大龟慢慢挺进我的体内视频| 国产精品你懂得| 国产麻豆91网在线看| 一级成人生活片免费看| 日韩国产成人精品视频| 亚洲日韩精品国产一区二区三区| 精品国产一区二区三区香蕉| 国产精品自产拍在线观看| 一级黄色免费毛片| 日本无卡无吗在线| 人人添人人妻人人爽夜欢视AV| 草莓视频黄色在线观看| 国产欧美一区二区另类精品 | 国产一起色一起爱| 精品国产一二三区在线影院| 在线免费观看一级毛片| 一出一进一爽一粗一大视频 | 午夜国产大片免费观看| 青青免费在线视频| 国产毛片哪里有| 2022国产麻豆剧果冻传媒剧情| 天天操夜夜操天天操| 亚洲av日韩综合一区二区三区| 漂亮人妻洗澡被公强| 又大又硬又爽免费视频| 青草影院内射中出高潮|